Pharmacy projects target SGLT2 inhibitors for heart failure

被引：0
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2023年 / 80卷 / 07期
关键词：
D O I：
10.1093/ajhp/zxad042
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：404 / 405
页数：2
相关论文
共 50 条
  • [21] EFFECT OF SGLT2 INHIBITORS ON THE ARRHYTHMIC BURDEN IN HEART FAILURE
    Vecchi, A.
    Saccinto, G.
    Bisceglia, F.
    De Ponti, R.
    Campana, C.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : ii89 - ii89
  • [22] Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure
    Cavallari, Ilaria
    Crispino, Simone Pasquale
    Segreti, Andrea
    Ussia, Gian Paolo
    Grigioni, Francesco
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (06) : 609 - 621
  • [23] SGLT2 inhibitors in heart failure with reduced ejection fraction
    Das, Uday Sankar
    Paul, Aritra
    Banerjee, Suvro
    EGYPTIAN HEART JOURNAL, 2021, 73 (01):
  • [24] The Sweet Spot: Heart Failure Prevention with SGLT2 Inhibitors
    Vardeny, Orly
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (02): : 182 - 185
  • [25] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [26] The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure
    Ji, Peng-juan
    Zhang, Zhuo-ya
    Yan, Qi
    Cao, Hui-li
    Zhao, Ya-jing
    Yang, Bing
    Li, Jin
    ESC HEART FAILURE, 2023, 10 (02): : 1314 - 1325
  • [27] SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
    Gupta, Rahul
    Maitz, Theresa
    Egeler, David
    Mehta, Anila
    Nyaeme, Mark
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Patel, Neel
    Aronow, Wilbert S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 479 - 486
  • [28] Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure
    Verbrugge F.H.
    Current Heart Failure Reports, 2017, 14 (4) : 275 - 283
  • [29] Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
    Evans, Marc
    Morgan, Angharad R.
    Yousef, Zaheer
    Ellis, Gethin
    Dashora, Umesh
    Patel, Dipesh C.
    Brown, Pam
    Hanif, Wasim
    Townend, Johnathan N.
    Kanumilli, Naresh
    Moore, Jim
    Wilding, John P. H.
    Bain, Stephen C.
    DRUGS, 2021, 81 (11) : 1243 - 1255
  • [30] Eligibility and reimbursement of SGLT2 inhibitors in a heart failure outpatient cohort
    Tarantini, Roberto
    Vecchi, Andrea Lorenzo
    Matteo, Federica
    Guerci, Marco
    De Ponti, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G125 - +
12345